A detailed history of Abel Hall, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Abel Hall, LLC holds 8,127 shares of PFE stock, worth $214,877. This represents 0.14% of its overall portfolio holdings.

Number of Shares
8,127
Previous 12,504 35.0%
Holding current value
$214,877
Previous $362 Million 40.42%
% of portfolio
0.14%
Previous 0.24%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 23, 2025

SELL
$24.8 - $30.19 $108,549 - $132,141
-4,377 Reduced 35.0%
8,127 $216 Million
Q3 2024

Nov 15, 2024

BUY
$27.7 - $31.39 $1,717 - $1,946
62 Added 0.5%
12,504 $362 Million
Q2 2024

Jul 25, 2024

SELL
$25.26 - $29.6 $8,942 - $10,478
-354 Reduced 2.77%
12,442 $348 Million
Q1 2024

May 08, 2024

BUY
$25.89 - $29.73 $37,695 - $43,286
1,456 Added 12.84%
12,796 $355 Million
Q4 2023

Feb 28, 2024

BUY
$26.13 - $33.94 $296,314 - $384,879
11,340 New
11,340 $326 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Abel Hall, LLC Portfolio

Follow Abel Hall, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Abel Hall, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Abel Hall, LLC with notifications on news.